Summary
Previous studies have demonstrated that the pathological features of breast cancer are more aggressive in younger women than in their older counterparts, and that young age may be an independent marker for adverse prognosis. These findings have raised the question whether these differences are also present at the molecular level. In order to characterize the genetic alterations associated with early-onset breast cancer, 102 cases selected for age under 37 at diagnosis were examined for loss of heterozygosity (LOH) at nine different loci on chromosomes 11, 13 and 17. Ninety cases (88%), exhibited LOH for at least one marker. The D17S855 marker, intragenic in the BRCA1 gene, showed a high proportion of LOH (63%), whereas the intragenic marker for the TP53 gene, HP53, exhibited LOH in 43% of the cases. On chromosome 11, frequencies of LOH peaked at the D11S969 and D11S387 markers, which expressed LOH in 53% and 48% of the informative cases, whereas D11S1818, which is proximate to the ATM gene, exhibited an LOH frequency of 24%. A statistically significant correlation was found between LOH at the D11S387 marker and poor survival (P = 0.028). No such correlation was found for the adjacent D11S969 marker, located approximately 500 kb centromeric to D11S387. We conclude that one or more as yet unidentified genes, situated in chromosome bands 11q24.1–q25, could be involved in the initiation and/or progression of breast cancer in younger women.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Adami, H. O., Malker, B., Holmberg, L., Persson, I. & Stone, B. (1986). The relation between survival and age at diagnosis in breast cancer. N Engl J Med 315: 559–563.
Albain, K. S., Allred, D. C. & Clark, G. M. (1994). Breast cancer outcome and predictors of outcome: are there age differentials?. J Natl Cancer Inst Monogr 16: 35–42.
Andersen, T. I., Gaustad, A., Ottestad, L., Farrants, G. W., Nesland, J. M., Tveit, K. M. & Borresen, A. L. (1992). Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p and 17q in human breast carcinomas. Genes Chromosomes Cancer 4: 113–121.
Beckmann, M. W., Picard, F., An, H. X., van Roeyen, C. R., Dominik, S. I., Mosny, D. S., Schnürch, H. G., Bender, H. G. & Niederacher, D. (1996). Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br J Cancer 73: 1220–1226.
Bevilacqua, G., Sobel, M. E., Liotta, L. A. & Steeg, P. S. (1989). Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 49: 5185–5190.
Bièche, I., Nogues, C., Rivoilan, S., Khodja, A., Latil, A. & Lidereau, R. (1997). Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma. Br J Cancer 76: 1416–1418.
Bonnier, P., Romain, S., Charpin, C., Lejeune, C., Tubiana, N., Martin, P. M. & Piana, L. (1995). Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer 62: 138–144.
Borg, A., Zhang, Q. X., Alm, P., Olsson, H. & Sellberg, G. (1992). The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Cancer Res 52: 2991–2994.
Caleffi, M., Teague, M. W., Jensen, R. A., Vnencak-Jones, C. L., Dupont, W. D. & Parl, F. F. (1994). p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment. Cancer 73: 2147–2156.
Chung, M., Chang, H. R., Bland, K. I. & Wanebo, H. J. (1996). Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 77: 97–103.
Cornelis, R. S., van Vliet, M., Vos, C. B., Cleton Jansen, A. M., van de Vijver, M. J., Peterse, J. L., Khan, P. M., Börresen, A. L., Cornelisse, C. J. & Devilee, P. (1994). Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. Cancer Res 54: 4200–4206.
de la Rochefordiere, A., Asselain, B., Campana, F., Scholl, S. M., Fenton, J., Vilcoq, J. R., Durand, J. C., Pouillart, P., Magdelenat, H. & Fourquet, A. (1993). Age as prognostic factor in premenopausal breast carcinoma. Lancet 341: 1039–1043.
Devilee, P., van Vliet, M., Bardoel, A., Kievits, T., Kuipers-Dijkshoorn, N., Pearson, P. L. & Cornelisse, C. J. (1991). Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma. Cancer Res 51: 1020–1025.
Easton, D. F. (1994). Cancer risks in A-T heterozygotes. Int J Radiat Biol 66: S177–S182.
Easton, D. F., Ford, D. & Bishop, D. T. (1995). Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56: 265–271.
Elledge, R. M. & Allred, D. C. (1994). The p53 tumor suppressor gene in breast cancer. Breast Cancer Res Treat 32: 39–47.
FitzGerald, M. G., Bean, J. M., Hegde, S. R., Unsal, H., MacDonald, D. J., Harkin, D. P., Finkelstein, D. M., Isselbacher, K. J. & Haber, D. A. (1997). Heterozygous ATM mutations do not contribute to early onset of breast cancer [see comments]. Nat Genet 15: 307–310.
Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L. M., Haugen-Strano, A., Swensen, J. & Miki, Y. (1994). BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120–122.
Greenblatt, M. S., Bennett, W. P., Hollstein, M. & Harris, C. C. (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855–4878.
Gudmundsson, J., Barkardottir, R. B., Eiriksdottir, G., Baldursson, T., Arason, A., Egilsson, V. & Ingvarsson, S. (1995). Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. Br J Cancer 72: 696–701.
Hennessy, C., Henry, J. A., May, F. E., Westley, B. R., Angus, B. & Lennard, T. W. (1991). Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J Natl Cancer Inst 83: 281–285.
Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C. C. (1991). p53 mutations in human cancers. Science 253: 49–53.
Host, H. & Lund, E. (1986). Age as a prognostic factor in breast cancer [published erratum appears in Cancer 1986 Aug 15;58(4):996]. Cancer 57: 2217–2221.
Jensen, D. E., Proctor, M., Marquis, S. T., Gardner, H. P., Ha, S. I., Chodosh, L. A., Ishov, A. M., Tommerup, N., Vissing, H., Sekido, Y., Minna, J., Borodovsky, A., Schultz, D. C., Wilkinson, K. D., Maul, G. G., Barlev, N., Berger, S. L., Prendergast, G. C. & Rauscher, FJIII (1998). BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16: 1097–1012.
Kaplan, E. & Meier, P. (1958). Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481.
Kerangueven, F., Allione, F., Noguchi, T., Adélaïde, J., Sobol, H., Jacquemier, J. & Birnbaum, D. (1995). Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumors. Genes Chromosomes Cancer 13: 291–294.
Kerangueven, F., Eisinger, F., Noguchi, T., Allione, F., Wargniez, V., Eng, C., Padberg, G., Theillet, C., Jacquemier, J., Longy, M. & Sobol, H. (1997). Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions. Oncogene 14: 339–347.
Knudson, A. G. Jr (1971). Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820–823.
Koreth, J., Bakkenist, C. J. & McGee, J. O. (1997). Allelic deletions at chromosome 11q22–q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers. Oncogene 14: 431–437.
Krainer, M., Silva Arrieta, S., FitzGerald, M. G., Shimada, A., Ishioka, C., Kanamaru, R., MacDonald, D. J., Unsal, H., Finkelstein, D. M., Bowcock, A., Isselbacher, K. J. & Haber, D. A. (1997). Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. N Engl J Med 336: 1416–1421.
Leone, A., Flatow, U., King, C. R., Sandeen, M. A., Margulies, I. M., Liotta, L. A. & Steeg, P. S. (1991). Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 65: 25–35.
Leone, A., Flatow, U., VanHoutte, K. & Steeg, P. S. (1993). Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 8: 2325–2333.
Lizard Nacol, S., Riedinger, J. M., Lizard, G., Glasser, A. L., Coudray, N., Chaplain, G. & Guerrin, J. (1997). Loss of heterozygosity at the TP53 gene: independent occurrence from genetic instability events in node-negative breast cancer.. Int J Cancer 72: 599–603.
Marcus, J. N., Watson, P., Page, D. L. & Lynch, H. T. (1994). Pathology and heredity of breast cancer in younger women. J Natl Cancer Inst Monogr: 23–34
Merajver, S. D., Pham, T. M., Caduff, R. F., Chen, M., Poy, E. L., Cooney, K. A., Weber, B. L., Collins, F. S., Johnston, C. & Frank, T. S. (1995). Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat Genet 9: 439–443.
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M. & Ding, W. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71.
Montagna, M., Serova, O., Sylla, B. S., Mattei, M. G. & Lenoir, G. M. (1996). Localization of the human phosphotyrosine phosphatase-related genes (h-PRL-1) to chromosome bands 1p35-p34, 17q12–q21, 11q24–q25 and 12q24. Hum Genet 98: 738–740.
Nagai, M. A., Pacheco, M. M., Brentani, M. M., Marques, L. A., Brentani, R. R., Ponder, B. A. & Mulligan, L. M. (1994). Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients. Br J Cancer 69: 754–758.
Nagai, M. A., Medeiros, A. C., Brentani, M. M., Brentani, R. R., Marques, L. A., Mazoyer, S. & Mulligan, L. M. (1995). Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors. Oncology 52: 448–453.
Niederacher, D., Picard, F., van Roeyen, C., An, H. X., Bender, H. G. & Beckmann, M. W. (1997). Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis. Genes Chromosomes Cancer 18: 181–192.
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hostetter, R., Cleary, K., Bigner, S. H., Davidson, N., Baylin, S. & Devilee, P. (1989). Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705–708.
Phelan, C. M., Lancaster, J. M., Tonin, P., Gumbs, C., Cochran, C., Carter, R., Ghadirian, P., Perret, C., Moslehi, R., Dion, F., Faucher, M. C., Dole, K., Karimi, S., Foulkes, W., Lounis, H., Warner, E., Goss, P., Anderson, D., Larsson, C., Narod, S. A. & Futreal, P. A. (1996). Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet 13: 120–122.
Sanford, K. K., Parshad, R., Price, F. M., Jones, G. M., Tarone, R. E., Eierman, L., Hale, P. & Waldmann, T. A. (1990). Enhanced chromatid damage in blood lymphocytes after G2 phase x irradiation, a marker of the ataxia-telangiectasia gene. J Natl Cancer Inst 82: 1050–1054.
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T. & Sfez, S. (1995). A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749–1753.
Schmutzler, R. K., Fimmers, R., Bierhoff, E., Lohmar, B., Homann, A., Speiser, P., Kubista, E., Jaeger, K., Krebs, D., Zeillinger, R. & Wiestler, O. D. (1996). Association of allelic losses on human chromosomal arms 11Q and 16Q in sporadic breast cancer. Int J Cancer 69: 307–311.
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T. & Livingston, D. M. (1997). Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88: 265–275.
Sherr, C. J. (1996). Cancer cell cycles. Science 274: 1672–1677.
Shibata, D., Brynes, R. K., Nathwani, B., Kwok, S., Sninsky, J. & Arnheim, N. (1989). Human immunodeficiency viral DNA is readily found in lymph node biopsies from seropositive individuals. Analysis of fixed tissue using the polymerase chain reaction. Am J Pathol 135: 697–702.
Sourvinos, G. & Spandidos, D. A. (1998). Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors. Biochem Biophys Res Commun 245: 75–80.
Stürzbecher, H. W., Donzelmann, B., Henning, W., Knippschild, U. & Buchhop, S. (1996). p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. EMBO J 15: 1992–2002.
Swift, M., Reitnauer, P. J., Morrell, D. & Chase, C. L. (1987). Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316: 1289–1294.
Swift, M., Morrell, D., Massey, R. B. & Chase, C. L. (1991). Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325: 1831–1836.
Swift, M. (1994). Ionizing radiation, breast cancer, and ataxia-telangiectasia [editorial; comment]. J Natl Cancer Inst 86: 1571–1572.
Szabo, C. I. & King, M. C. (1995). Inherited breast and ovarian cancer. Hum Mol Genet 4: 1811–1817.
Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., Stoppa-Lyonnet, D., Belanger, C., Bell, R., Berry, S., Bogden, R., Chen, Q., Davis, T., Dumont, M., Frye, C., Hattier, T. & Jammulapati, S. (1996). The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12: 333–337.
Vaughn, J. P., Cirisano, F. D., Huper, G., Berchuck, A., Futreal, P. A., Marks, J. R. & Iglehart, J. D. (1996). Cell cycle control of BRCA2. Cancer Res 56: 4590–4594.
Vorechovsky´, I., Luo, L., Lindblom, A., Negrini, M., Webster, A. D., Croce, C. M. & Hammarström, L. (1996). ATM mutations in cancer families. Cancer Res 56: 4130–4133.
Vorechovsky´, I., Rasio, D., Luo, L., Monaco, C., Hammarström, L., Webster, A. D., Zaloudik, J., Barbanti-Brodani, G., James, M. & Russo, G. (1996). The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res 56: 2726–2732.
Walker, R. A., Lees, E., Webb, M. B. & Dearing, S. J. (1996). Breast carcinomas occurring in young women (< 35 years) are different. Br J Cancer 74: 1796–1800.
Wenger, C. R., Beardslee, S., Owens, M. A., Pounds, G., Oldaker, T., Vendely, P., Pandian, M. R., Harrington, D., Clark, G. M. & McGuire, W. L. (1993). DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients. Breast Cancer Res Treat 28: 9–20.
Westphal, C. H., Rowan, S., Schmaltz, C., Elson, A., Fisher, D. E. & Leder, P. (1997). ATM and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat Genet 16: 397–401.
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C. & Micklem, G. (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789–792.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Gentile, M., Olsen, K., Dufmats, M. et al. Frequent allelic losses at 11q24.1–q25 in young women with breast cancer: association with poor survival. Br J Cancer 80, 843–849 (1999). https://doi.org/10.1038/sj.bjc.6690430
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690430
Keywords
This article is cited by
-
Aberrant BLID expression is associated with breast cancer progression
Tumor Biology (2014)
-
BRCC2 inhibits breast cancer cell growth and metastasis in vitro and in vivo via downregulating AKT pathway
Cell Death & Disease (2013)
-
Prise en charge du cancer du sein infiltrant de la femme âgée de 40 ans ou moins
Oncologie (2011)
-
Increasing expression of serine protease matriptase in ovarian tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters
Modern Pathology (2006)
-
Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition
British Journal of Cancer (2002)